Immunoprofiling of the Patient Tumor Microenvironment in BCMA Targeted Therapies

Study acronym: IMPACT
StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The main goal of the project is to characterize the bone marrow immunological milieu and investigate potential treatment defining events of the tumor microenvironment in relapsed and refractory multiple myeloma (RRMM) patients receiving BCMA-targeted therapies.
Trial Details
NCT Number NCT07878208
Lead Sponsor Odense University Hospital
Collaborators: Oslo University Hospital
Conditions
(from sponsor)		 Myeloma
Related terms Neoplasms, Plasma Cell
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov